Literature DB >> 2849674

Correlation between binding affinities for brain A1 and A2 receptors of adenosine agonists and antagonists and their effects on heart rate and coronary vascular tone.

H H Oei1, G R Ghai, H C Zoganas, G A Stone, M B Zimmerman, F P Field, M Williams.   

Abstract

The activities of a series of A1 and A2 adenosine receptor agonists and antagonists were determined using radioligand binding techniques in rat brain tissues. The potencies of these agonists on heart rate and coronary vascular tone were also assessed in the perfused working rat heart preparation. The order of potency of these agonists in producing negative chronotropic effects was similar to the rank order for their A1 receptor binding activities [6-N-cyclohexyladenosine (CHA) = 6-N-(R-phenylisopropyl)-adenosine greater than 5'-N-ethylcarboxamideadenosine (NECA) = 2-chloroadenosine greater than 2-phenylaminoadenosine] with a correlation coefficient of 0.97. Their order of potency in reducing coronary vascular tone followed the same rank order as their A2 receptor binding activities with a correlation coefficient of 0.97 (NECA greater than 2-chloroadenosine = 6-N-(R-phenylisopropyl)-adenosine = 2-phenylaminoadenosine greater than CHA). In addition, the antagonists 8-[4-[[[[(2-aminoethyl)amino]carbonyl]methyl]ox]phenyl-1,3- dipropylxanthine (XAC), 1,3-dipropyl-8-(2-amino-4-chlorophenyl) xanthine (PACPX) and 8-phenyltheophylline (8-PT) blocked the negative chronotropic effect of CHA and the vasodilatory effect of NECA in a concentration-dependent manner. The same order of potency of the antagonists was noted in blocking CHA-induced bradycardia and A1 receptor binding activities (XAC = PACPX greater than 8-PT). A similar correlation was observed for their effects in blocking NECA-induced vasodilation and A2 receptor binding activity (XAC greater than PACPX greater than 8-PT).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849674

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling.

Authors:  K N Klotz; H Vogt; H Tawfik-Schlieper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

3.  The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium.

Authors:  Clare J Ray; Janice M Marshall
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

4.  Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs.

Authors:  A J Szentmiklósi; A Ujfalusi; A Cseppentö; K Nosztray; P Kovács; J Z Szabó
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

5.  Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.

Authors:  R A Mathôt; E M Van der Wenden; W Soudijn; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

6.  Adenosine-induced dilatation of the rabbit hepatic arterial bed is mediated by A2-purinoceptors.

Authors:  R T Mathie; B Alexander; V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

7.  Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.

Authors:  S Appel; R A Mathôt; M W Langemeijer; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

8.  Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues.

Authors:  A Conti; A Monopoli; M Gamba; P A Borea; E Ongini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

9.  An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.

Authors:  P Dorigo; R M Gaion; P Belluco; L Mosti; P A Borea; I Maragno
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

10.  Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.

Authors:  R A Mathôt; A Cleton; W Soudijn; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.